CervoMed Inc. — Director's Dealing 2016

Dec 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Diffusion Pharmaceuticals Inc. (DFFN)
CIK: 0001053691
Period of Report: 2016-12-08

Reporting Person: Shealy Ben (Sr VP Finance & Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-08	Stock Option (Right to Buy)	$2.74	A	16000	Acquired	2026-12-08	Common Stock (16000)	Direct

Footnotes

F1: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on November 30, 2019.